Nine public companies just told crypto their stocks aren't welcome onchain — at least not on this venue.

An October 15 public notice from OKXICE — the joint venture between OKX and NYSE parent Intercontinental Exchange — disclosed nine issuer objections: Broadcom, Verizon, UnitedHealth, CoreWeave, Cerebras, AppLovin, Applied Digital, Rocket Lab, and Applied Optoelectronics. Nasdaq separately said it won't tokenize its own shares under the framework.

OKXICE plans 24/7 trading of one-for-one-backed tokenized stocks under the SEC's five-year Innovation Exemption. But the exemption hands issuers a 30-day veto window — and they're using it.

CoinShares' Luke Nolan called the veto venue-specific, not a rejection of tokenization itself. TD Securities flagged the deeper problem: temporary relief, not permanent rules — and institutions won't build on something a future commission can reverse.

The irony writes itself: the fully regulated, 1:1-backed product needs permission; the synthetic knockoffs need none.

Does issuer consent slow tokenized stocks to a crawl, or force venues to build with companies from day one? NFA, DYOR.